@inproceedings{inproceedings, title  = {{383 Integrated safety analysis of abrocitinib in 635 adolescent patients with moderate-to-severe atopic dermatitis with over 1000 patient-years of exposure}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{http://dx.doi.org/10.1093/bjd/ljad162.011 }},

 year = {{2023}},

 month = {{6}},

 author = {{Paller AS and Eichenfield LF and Silverberg JI and Cork MJ and Bangert C and Irvine AD and Weidinger S and Barbarot S and Fan H and Alderfer J and Koppensteiner H et al}},

 doi = {{10.1093/bjd/ljad162.011}},

 volume = {{188}},

 journal = {{British Journal of Dermatology}},

 issue = {{Supplement_3}},

 note = {{Accessed on 2024/12/22}}}